InvestorsHub Logo
icon url

mc67

10/07/20 4:05 PM

#25473 RE: GreenKnight #25472

Yes, " Because of its lack of toxicity and low cost of manufacture compared to proprietary biologics, VIP may be uniquely attractive to those focused on global countermeasures against COVID-19."